《中国康复理论与实践》

中国康复理论与实践 >

2020 , Vol. 26 >Issue 5: 588 - 591

DOI: https://doi.org/10.3969/j.issn.1006-9771.2020.05.019

临床研究

microRNA-137基因多态性与缺血性卒中后抑郁的相关性

  • 符家武 ,
  • 吴昊 ,
  • 李君良 ,
  • 叶烨 ,
  • 陈婧 ,
  • 周海红 ,
  • 李友
展开
  • 广东医科大学附属医院神经内科,广东湛江市 524001
符家武(1985-),男,汉族,广东湛江市人,硕士,主治医师,主要研究方向：脑血管病及精神障碍疾病基础与临床。

收稿日期: 2019-10-29

  修回日期: 2020-01-20

  网络出版日期: 2020-05-29

基金资助

1. 国家自然科学基金项目(81571157);2. 湛江市科技计划项目(2019A01024)

收起

Association between microRNA-137 Gene Polymorphisms and Ischemic Post-stroke Depression

  • Jia-wu FU ,
  • Hao WU ,
  • Jun-liang LI ,
  • Ye YE ,
  • Jing CHEN ,
  • Hai-hong ZHOU ,
  • You LI
Expand
  • Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524001, China

Received date: 2019-10-29

  Revised date: 2020-01-20

  Online published: 2020-05-29

Supported by

National Science Foundation of China(81571157);Zhanjiang Research and Development Plan(2019A01024)

Fold

摘要

目的 分析microRNA-137基因多态性与缺血性卒中后抑郁的相关性。方法 2017年1月至2019年1月,SNaPshot检测缺血性卒中后抑郁患者250例(患者组)和健康体检者250例(对照组) microRNA-137基因rs1625579位点的基因型,逆转录荧光定量聚合酶链反应检测外周血单个核细胞microRNA-137相对表达量,并分析其与rs1625579位点不同基因型的关系。结果 患者组rs1625579位点等位基因T高于对照组(OR = 2.033, 95%CI 1.255~3.294, P= 0.003),基因型TT高于对照组 (OR = 2.139, 95%CI 1.272~3.595, P= 0.004);患者组microRNA-137相对表达量显著低于对照组(t = 28.230, P< 0.001);对照组TT基因型的microRNA-137相对表达量显著低于GT+GG基因型(t = 3.764, P< 0.001)。结论 microRNA-137基因rs1625579位点TT基因型可能通过下调microRNA-137的表达,参与缺血性卒中后抑郁的发病。

关键词： 缺血性脑卒中; 卒中后抑郁; microRNA-137; rs1625579; 基因多态性

本文引用格式

符家武 , 吴昊 , 李君良 , 叶烨 , 陈婧 , 周海红 , 李友 . microRNA-137基因多态性与缺血性卒中后抑郁的相关性[J]. 中国康复理论与实践, 2020 , 26(5) : 588 -591 . DOI: 10.3969/j.issn.1006-9771.2020.05.019

Abstract

Objective To analyze the relationship between microRNA-137 gene polymorphisms and ischemic post-stroke depression (PSD).Methods January, 2017 to January, 2019, the single nucleotide polymorphism (SNP) of rs1625579 in microRNA-137 was genotyped in 250 ischemic PSD patients and 250 healthy controls with SNaPshot. The expression of microRNA-137 was measured with quantitative real-time polymerase chain reaction in the mononuclear cells, and the association of the SNP rs1625579 with microRNA-137 expression was analyzed.Results The allele T was more in the patients than in the controls (OR = 2.033, 95%CI 1.255 to 3.294, P= 0.003), as well as the genotype TT (OR = 2.139, 95%CI 1.272~3.595, P= 0.004). The microRNA-137 expression was less in the patients than in the controls (t = 28.23, P< 0.001). For the controls, the microRNA-137 expression was also less in those with genotype of TT than with GT and GG (t = 3.764, P< 0.001).Conclusion The genotype TT of SNP rs1625579 in microRNA-137 is a risk factor of susceptibility to ischemic PSD, which may associate with the decrease of expression of microRNA-137.

Key words： ischemic stroke; post-stroke depression; microRNA-137; rs1625579; gene polymorphisms

参考文献

[1] GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet, 2016, 388(10053):1459-1544.
[2] Chugh C. Acute ischemic stroke: management approach[J]. Indian J Crit Care Med, 2019, 23(Suppl 2):S140-S146.
[3] Xiong Y, Manwani B, Fisher M. Management of acute ischemic stroke[J]. Am J Med, 2019, 132(3):286-291.
[4] Robinson R G, Jorge R E. Post-stroke depression: a review[J]. Am J Psychiatry, 2016, 173(3):221-231.
[5] Cai W, Mueller C, Li Y J, et al. Post stroke depression and risk of stroke recurrence and mortality: a systematic review and meta-analysis[J]. Ageing Res Rev, 2019, 50:102-109.
[6] Paolucci S, Iosa M, Coiro P, et al. Post-stroke depression increases disability more than 15% in ischemic stroke survivors: a case-control study[J]. Front Neurol, 2019, 10:926.
[7] Miranda J J, Moscoso M G, Toyama M, et al. Role of mHealth in overcoming the occurrence of post-stroke depression[J]. Acta Neurol Scand, 2018, 137(1):12-19.
[8] Lu T X, Rothenberg M E. MicroRNA[J]. J Allergy Clin Immunol, 2018, 141(4):1202-1207.
[9] Biggar K K, Storey K B. Functional impact of microRNA regulation in models of extreme stress adaptation[J]. J Mol Cell Biol, 2018, 10(2):93-101.
[10] Jolana L, Kamil D. The role of microRNA in ischemic and hemorrhagic stroke[J]. Curr Drug Deliv, 2017, 14(6):816-831.
[11] 鲁豫, 田小军, 史莉瑾, 等. MiR-137在缺血性卒中后抑郁患者外周血中的表达及其临床意义[J]. 临床神经病学杂志, 2017, 30(3):217-220.
[12] Zhao L, Li H, Guo R, et al. miR-137, a new target for post-stroke depression?[J]. Neural Regen Res, 2013, 8(26):2441-2448.
[13] Zar M S, Shahid A A, Shahzad M S, et al. Forensic SNP Genotyping with SNaPshot: development of a novel in-house SBE multiplex SNP assay[J]. J Forensic Sci, 2018, 63(6):1824-1829.
[14] Hackett M L, Yapa C, Parag V, et al. Frequency of depression after stroke: a systematic review of observational studies[J]. Stroke, 2005, 36(6):1330-1340.
[15] Hadidi N N, Huna Wagner R L, Lindquist R. Nonpharmacological treatments for post-stroke depression: an integrative review of the literature[J]. Res Gerontol Nurs, 2017, 10(4):182-195.
[16] Ibrahimagic O C, Smajlovic D, Kunic S, et al. Post-stroke depression[J]. Mater Sociomed, 2019, 31(1):31-34.
[17] Tan K S, Armugam A, Sepramaniam S, et al. Expression profile of MicroRNAs in young stroke patients[J]. PLoS One, 2009, 4(11):e7689.
[18] Tavakolizadeh J, Roshanaei K, Salmaninejad A, et al. MicroRNAs and exosomes in depression: potential diagnostic biomarkers[J]. J Cell Biochem, 2018, 119(5):3783-3797.
[19] Smalheiser N R, Lugli G, Rizavi H S, et al. MicroRNA expression is down-regulated and reorganized in prefrontal cortex of depressed suicide subjects[J]. PLoS One, 2012, 7(3):e33201.
[20] 杨晓煜, 史齐, 褚秀峰, 等. 卒中后抑郁模型大鼠与miR-137抑制下的Grin2A表达[J]. 中国组织工程研究, 2015, 19(24):3832-3838.
[21] Ripke S, Sanders A R, Kendler K S, et al. Genome-wide association study identifies five new schizophrenia loci[J]. Nat Genet, 2011, 43(10):969-976.
Options
文章导航

/

〈 〉